Vedanta Biosciences

Vedanta Biosciences

Vedanta Biosciences

Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome.
Raised
$95.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$18,500,000
Venture capital (Series C) - 2019
Partners Investment Shumway Capital JSR +1
$27,000,000
Venture capital (Series C) - 2018
Team Size
1–10
Employees
$27,000,000 Venture capital (Series C)
StartupWorld , Xconomy , FinSMEs

Vedanta Biosciences Raises $27 Million Series C Financing

$50,000,000 Venture capital
FinSMEs

Microbiome Therapeutics Company Vedanta Biosciences Raises $50M in VC Funding

Health Funding Science